Filana Therapeutics, Inc.
FLNA
Rank in Stocks
#25784
Filana Therapeutics, Inc. is a company dedicated to pioneering new... Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Share Price
$0.4923
Last synced: 2026-11-09
Market Cap
$23.78M
Change (1 day)
8.75%
Change (1 year)
-
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Filana Therapeutics, Inc. (FLNA)
Category
Healthcare
Operating Margin for Filana Therapeutics, Inc. (FLNA)
Operating Margin as of November 2026 TTM: 0.00%
According to Filana Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Filana Therapeutics, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | 76.28% | -313.13% |
| 2012 | -35.79% | 16.96% |
| 2011 | -30.60% | -62.46% |
| 2010 | -81.52% | 148.16% |
| 2009 | -32.85% | -340.31% |
| 2008 | 13.67% | -11.29% |
| 2007 | 15.41% | -1,596.12% |
| 2006 | -1.03% | -99.84% |
| 2005 | -644.04% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | -100.00% |
| 2002 | 14,841.23% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Filana Therapeutics, Inc.'s operating margin
What was Filana Therapeutics, Inc.'s operating margin in 2025?
In 2025, Filana Therapeutics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Filana Therapeutics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Filana Therapeutics, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Filana Therapeutics, Inc.'s operating margin compare with similar companies?
Filana Therapeutics, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.